Diabetes Research Centers (P30 Clinical Trial Optional)
About
This Notice of Funding Opportunity (NOFO) invites applications for Diabetes Research Centers (DRCs) that are designed to support and enhance the national research effort in diabetes, its complications, and related endocrine and metabolic diseases. The purpose of this Centers program is to bring together basic and clinical investigators to enhance communication, multidisciplinary collaboration, and effectiveness of ongoing research in Diabetes Research Center topic areas. By providing shared access to specialized technical resources (research cores) and supporting a Pilot and Feasibility Program (P&F), DRCs are intended to create an environment that provides the capability for accomplishments greater than those that would be possible by individual research project grant support alone. New Center programs that bring in diverse perspectives, propose unique scientific themes, or provide innovative resources are encouraged. Emphasis will be placed on Center programs that propose enhanced synergies with other NIDDK-funded programs as well as providing a rich mentoring environment for future diabetes researchers.
The Diabetes Research Centers (P30 Clinical Trial Optional) grant is designed for research institutions and academic medical centers committed to advancing diabetes research and related endocrine and metabolic diseases. This Notice of Funding Opportunity (NOFO) supports the establishment of comprehensive research centers that bring together multidisciplinary teams of basic and clinical investigators to enhance collaboration and accelerate scientific discovery. The program provides institutions with shared access to specialized research cores and supports pilot and feasibility projects, creating an environment where collaborative efforts produce greater outcomes than individual research projects alone. Institutions should apply if they can propose innovative scientific themes, unique resources, or enhanced synergies with other NIDDK-funded programs, and are committed to mentoring future diabetes researchers. This is an excellent opportunity for research-focused organizations seeking to establish or strengthen their diabetes research infrastructure, expand their investigative capacity, and contribute meaningfully to the national diabetes research effort. The grant encourages diversity of perspectives and novel approaches to understanding diabetes and its complications.
Funding Facts
● Applications openDeadline
January 27, 2027
Award Amount
Up to $1M
Who can apply
Last verified July 5, 2026 · Source: Grants.gov
Grant Details
Grant Amount
Up to $1M
Deadline
2027-01-27
Grant Type
federal
Application Cycle
Annual (Deadline: January 27, 2027)
Best For
Research institutions, academic medical centers, universities with established diabetes research programs and multidisciplinary investigative teams
Eligibility
Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. Special Instructions for this NOFO: Only one application is allowed per institution.Foreign Organizations/International CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Frequently Asked Questions
Who is eligible for Diabetes Research Centers (P30 Clinical Trial Optional)?
Eligible applicants are U.S.-based institutions capable of supporting comprehensive diabetes research centers. Foreign organizations and non-domestic components of U.S. organizations are not eligible. Only one application per institution is permitted. For complete eligibility requirements, including institutional qualifications and specific criteria, refer to Section III of the official Notice of Funding Opportunity (NOFO) on the NIH website.
How much funding does Diabetes Research Centers (P30 Clinical Trial Optional) provide?
Funding ranges from N/A to $1,000,000, though specific award amounts may vary by application cycle and institutional needs. For current funding details and budget guidelines, consult the official NOFO and the NIH grants portal.
How do I apply for Diabetes Research Centers (P30 Clinical Trial Optional)?
Applications are submitted through the NIH electronic submission system (eRA Commons/Grants.gov). The application deadline is January 27, 2027. Prospective applicants should review the complete NOFO for submission requirements, required components, and formatting guidelines. Only one application per institution will be accepted. For detailed instructions and technical assistance, visit the NIH official website and consult your institution's research administration office.
What can Diabetes Research Centers (P30 Clinical Trial Optional) funding be used for?
Funding supports the establishment and operation of diabetes research centers, including specialized research cores, pilot and feasibility programs, and shared technical resources. Centers can support multidisciplinary research addressing diabetes, its complications, and related endocrine and metabolic diseases. Funding also supports mentoring programs for future diabetes researchers and facilitates collaboration among investigators. For specific allowable uses and budget categories, review the official NOFO guidelines.
Last updated: July 5, 2026